Insider Selling: CryoPort (NASDAQ:CYRX) CEO Sells $63,344.00 in Stock

CryoPort, Inc. (NASDAQ:CYRX) CEO Jerrell Shelton sold 7,918 shares of the stock in a transaction dated Monday, March 16th. The stock was sold at an average price of $8.00, for a total transaction of $63,344.00. Following the sale, the chief executive officer directly owned 1,054,501 shares in the company, valued at approximately $8,436,008. This represents a 0.75% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

CryoPort Trading Up 2.1%

Shares of NASDAQ CYRX opened at $8.29 on Friday. CryoPort, Inc. has a 1-year low of $4.63 and a 1-year high of $11.45. The company has a 50-day moving average of $9.10 and a two-hundred day moving average of $9.35. The company has a market cap of $413.34 million, a PE ratio of 6.28 and a beta of 1.69.

CryoPort (NASDAQ:CYRX) last issued its quarterly earnings results on Tuesday, March 3rd. The company reported ($0.21) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.02). CryoPort had a net margin of 42.35% and a negative return on equity of 8.22%. The company had revenue of $45.45 million during the quarter, compared to analyst estimates of $42.92 million. As a group, equities research analysts forecast that CryoPort, Inc. will post -0.99 earnings per share for the current year.

Institutional Trading of CryoPort

Hedge funds have recently modified their holdings of the company. Millennium Management LLC grew its holdings in CryoPort by 23.8% during the fourth quarter. Millennium Management LLC now owns 3,244,802 shares of the company’s stock valued at $31,150,000 after purchasing an additional 623,896 shares during the period. Vanguard Group Inc. grew its holdings in shares of CryoPort by 2.5% in the 3rd quarter. Vanguard Group Inc. now owns 2,858,031 shares of the company’s stock valued at $27,094,000 after buying an additional 69,550 shares during the period. Thematics Asset Management increased its position in shares of CryoPort by 12.8% in the 2nd quarter. Thematics Asset Management now owns 1,914,885 shares of the company’s stock valued at $14,285,000 after buying an additional 216,937 shares in the last quarter. Assenagon Asset Management S.A. raised its stake in CryoPort by 37.4% during the 3rd quarter. Assenagon Asset Management S.A. now owns 1,498,774 shares of the company’s stock worth $14,208,000 after buying an additional 408,263 shares during the period. Finally, UBS Group AG grew its stake in CryoPort by 6.8% in the fourth quarter. UBS Group AG now owns 1,421,884 shares of the company’s stock valued at $13,650,000 after acquiring an additional 90,363 shares during the period. 92.90% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts recently commented on the company. Needham & Company LLC lifted their price objective on CryoPort from $12.00 to $13.00 and gave the stock a “buy” rating in a research report on Wednesday, March 4th. Wall Street Zen lowered shares of CryoPort from a “hold” rating to a “sell” rating in a research note on Saturday, March 7th. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of CryoPort in a research note on Monday, December 29th. Eight equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $12.94.

CryoPort Company Profile

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.